61 reports

Patients will be randomized (##:##) to MSB-## or placebo for one week.

  • Dermatological Condition
  • Gastrointestinal Drug
  • Therapy
  • United States
  • Synthetic Biologics

Our Gastrointestinal Portfolio.

  • Gastrointestinal Drug
  • Allergan plc
  • Ardelyx, Inc.
  • Astellas Pharma Inc.
  • Ironwood Pharmaceuticals, Inc.

GASTROINTESTINAL BLEEDING (GASTROINTESTINAL HEMORRHAGE) THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* CLINICAL TRIALS BY PHASE IN E## COUNTRIES GASTROINTESTINAL BLEEDING (GASTROINTESTINAL HEMORRHAGE) THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHAS

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • World
  • Product Initiative

Gut and Liver; ##(##):##-##.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • Italy
  • Forecast

The most frequently reported AEs were within the gastrointestinal system organ class. http:/ / ep##. eventpilot. us/ web/ page. php?

  • Gastrointestinal Drug
  • North America
  • United States
  • World
  • Furiex Pharmaceuticals, Inc.

The prominent features of this report are - ##.

  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited

The prominent features of this report are - ##.

  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited

The prominent features of this report are - ##.

  • Drug Discovery And Development
  • Gastrointestinal Drug
  • United States
  • World
  • Salix Pharmaceuticals, Ltd.

(Inactive) ## ## ## ## ## ## UCB S. A. ## ## ## ## ## ## Ocera Therapeutics, Inc. ## ## ## ## ## ## Debiopharm Group ## ## ## ## ## ## Advanced Clinical, LLC ## ## ## ## ## ## Abbott Laboratories ## ## ## ## ## ## Charles River Laboratories Intern

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • World
  • Product Initiative

The usage of opioids and their adverse effects in gastrointestinal practice: a review.

  • Gastrointestinal Drug
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Progenics Pharmaceuticals, Inc.
  • Salix Pharmaceuticals, Ltd.

PROPORTION OF NONEROSIVE REFLUX DISEASE (NERD) TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2018* PROPORTION OF NONEROSIVE REFLUX DISEASE (NERD) TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2018* PROPORTION OF NONEROSIVE REFLUX DISEASE (NERD) TO

  • Gastrointestinal Drug
  • Therapy
  • World
  • Product Initiative
  • Takeda Pharmaceutical Company Limited

The prominent features of this report are - ##.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pathology
  • World
  • Product Initiative

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC

## ## ## ## ## ## ## ## ## ## ## ## GlaxoSmithKline Plc ## ## ## ## Epworth HealthCare Dianthus Medical Limited (Inactive) ## ## ## ## ## ## ## ## Cook Medical Inc Source: GlobalData' s Pharma Intelligence Center

  • Gastrointestinal Drug
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative

Menarini Industrie Farmaceutiche Riunite Srl Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2018 2018 trials are taken as of May 2018 ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ##

  • Clinical Trial
  • Gastrointestinal Drug
  • Pharmaceutical
  • Therapy
  • World

The prominent features of this report are - ##.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • World
  • Takeda Pharmaceutical Company Limited

The prominent features of this report are - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • Merck & Co., Inc.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • Product Initiative

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Drug Discovery And Development
  • Gastrointestinal Drug
  • World
  • Product Initiative
  • AstraZeneca PLC

According to the International Foundation for Functional Gastrointestinal Disorders, IBS is the most common functional gastrointestinal disorder.

  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Company
  • Ferring International Center S.A.

Linaclotide Delayed Release-## (DR##).

  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Company Financials
  • Ironwood Pharmaceuticals, Inc.

The prominent features of this report are - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World

The prominent features of this report are - ##.

  • Clinical Trial
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • Product Initiative

IBS is one of the most common gastrointestinal disordersiii.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • GlaxoSmithKline plc

The prominent features of this report are - ##.

  • Clinical Trial
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • Product Initiative

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • World
  • Product Initiative

IBS is one of the most common gastrointestinal disorders##.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • Product Initiative